Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Hemispherx Biopharma Reports Evidence Based Clinical Potential of a Natural Interferon (IFN) -- Alpha for Infection Control and Treatment of Drug Resistant H7N9 Influenza Virus

Globe Newswire January 7, 2014

Celator(R) Pharmaceuticals Approved for Approximately $1.5 Million From New Jersey's Technology Business Tax Certificate Transfer Program

Globe Newswire January 7, 2014

International Stem Cell Corporation to Present at Biotech Showcase 2014

Marketwired January 7, 2014

DivX DRM Receives Conditional Approval for UltraViolet(TM) Digital Downloads

Business Wire January 7, 2014

Harmonyx Lab Earns Accreditation from the College of American Pathologists

Business Wire January 7, 2014

Good Start Genetics to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Business Wire January 7, 2014

Mice Model Market worth $1,819.9 Million by 2018

PR Newswire January 7, 2014

AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources

Globe Newswire January 7, 2014

Entropic, TVSTORM Develop Android-Based IP Set-Top Box With Miracast Functionality

Globe Newswire January 7, 2014

StemCells, Inc. to Discuss Plans for Advancing Clinical Studies in Spinal Cord Injury and Age Related Macular Regeneration

Globe Newswire January 7, 2014

Oracle Health Sciences Translational Research Center 3.0 Helps Advance Personalized Medicine

Marketwired January 7, 2014

Forma Therapeutics Appoints Christopher Dinsmore to Vice President, Medicinal and Computational Chemistry

Business Wire January 7, 2014

ISTO Technologies Appoints James McGorry to Board of Directors

PR Newswire January 7, 2014

Data Sciences International acquires Buxco Research Company to expand preclinical research solutions offering

PR Newswire January 7, 2014

Emmaus Medical Announces Completion Of All Patient Visits For Its Phase 3 Clinical Trial For Treatment Of Sickle Cell Disease

PR Newswire January 7, 2014

IHV Supports REPEAL HIV Discrimination Act

PR Newswire January 7, 2014

Kite Pharma to Present at the 32nd Annual J.P. Morgan Healthcare Conference

PR Newswire January 7, 2014

Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing

PR Newswire January 7, 2014

Health Robotics Reports 221 Net New Contracts in 2013 (232% of 2012's Sales Bookings), with 51 Units in 4Q

Business Wire January 7, 2014

Omicia Raises $6.8 Million to Accelerate Whole Genome Interpretation

Business Wire January 7, 2014